7724 Federal Register / Vol. 86, No. 19 / Monday, February 1, 2021 / Notices 

For Transferor and Transferee: Mr. 

Matthew D. Manahan, Counsel for 

Transferor and Transferee, Pierce 

Atwood LLP, 254 Commercial St., 

Portland, ME 04101, phone: (207) 791– 

1189, Email: mmanahan@

pierceatwood.com. 

i. FERC Contact: Mrs. Anumzziatta 

Purchiaroni, (202) 502–6191 or 

Anumzziatta.purchiaroni@ferc.gov. 

j. Deadline for filing comments, 

motions to intervene, and protests: 

Within 30 days from the issuance date 

of this notice. 

The Commission strongly encourages 

electronic filing. Please file comments, 

motions to intervene, and protests using 

the Commission’s eFiling system at 

http://www.ferc.gov/docs-filing/ 

efiling.asp. Commenters can submit 

brief comments up to 6,000 characters, 

without prior registration, using the 

eComment system at http://

www.ferc.gov/docs-filing/ 

ecomment.asp. You must include your 

name and contact information at the end 

of your comments. For assistance, 

please contact FERC Online Support at 

FERCOnlineSupport@ferc.gov, (866) 

208–3676 (toll free), or (202) 502–8659 

(TTY). In lieu of electronic filing, please 

send a paper copy to: Kimberly D. Bose, 

Secretary, Federal Energy Regulatory 

Commission, 888 First Street NE, Room 

1A, Washington, DC 20426. 

Submissions sent via any other carrier 

must be addressed to: Kimberly D. Bose, 

Secretary, Federal Energy Regulatory 

Commission, 12225 Wilkins Avenue, 

Rockville, Maryland 20852. The first 

page of any filing should include docket 

number P–2897–052, P–2931–044, P– 

2932–051, P–2941–047, P–2942–054, 

and P–2984–123. Comments emailed to 

Commission staff are not considered 

part of the Commission record. 

The Commission’s Rules of Practice 

and Procedure require all intervenors 

filing documents with the Commission 

to serve a copy of that document on 

each person on the official service list 

for the project. Further, if an intervenor 

files comments or documents with the 

Commission relating to the merits of an 

issue that may affect the responsibilities 

of a resource agency, it must also serve 

a copy of the document on that resource 

agency. 

k. Description of Transfer and Lease 

of Project Lands Request: The applicants 

request that the Commission approve 

the transfer of the following projects 

from Sappi North America, Inc. (Sappi 

or Transferor) to Presumpscot Hydro 

LLC (Presumpscot or Transferee): 

Saccarappa Project No. 2897, Gambo 

Project No. 2931, Mallison Falls Project 

No. 2932, Little Falls Project No. 2941, 

Dundee Project No. 2942, and Eel Weir 

Project No. 2984–123. The applicants 

propose the transfer because of an 

internal corporate reorganization that 

resulted in the formation of the Sappi 

subsidiary, Presumpscot. As part of the 

proposed transfers, the Transferor 

would retain ownership of the 

transmission line properties between 

the Dundee Project and Transferor’s 

Westbrook Mill. In addition, the 

Transferor would retain ownership of 

the transmission line properties 

between the Mallison Falls Project and 

Transferors’ Westbrook Mill (which 

transmission line connects the Gambo, 

Little Falls, and Mallison Falls projects 

to the mill). The applicants request 

Commission approval to lease the 

transmission line property to the 

Transferee. Furthermore, the Transferor 

requests approval to lease to the 

Transferee certain lands associated with 

the Saccarappa Project, including 

property associated with required fish 

passage facilities. By an Order issued on 

April 4, 2019, the Commission approved 

a surrender of the Saccarappa Project 

license and related license amendments 

for the Mallison Falls, Little Falls, 

Gambo, and Dundee Projects. The 

license surrender would become 

effective upon removal of the 

Saccarappa Dam and other project 

works, installation of fish passage 

facilities, and the completion of other 

requirements. The completed fish 

passage facilities would become part of 

the Mallison Falls Project. The 

applicants also request Commission 

approval to convey in fee the proposed 

leased lands occupied by the fish 

passage facilities to the Transferee once 

the surrender becomes effective. 

l. Locations of the Applications: The 

Commission provides all interested 

persons an opportunity to view and/or 

print the contents of this document via 

the internet through the Commission’s 

website at http://www.ferc.gov/docsfiling/elibrary.asp. Enter the docket 

number excluding the last three digits in 

the docket number field to access the 

document. You may also register online 

at http://www.ferc.gov/docs-filing/ 

esubscription.asp to be notified via 

email of new filings and issuances 

related to this or other pending projects. 

Agencies may obtain copies of the 

application directly from the applicants. 

At this time, the Commission has 

suspended access to the Commission’s 

Public Reference Room due to the 

proclamation declaring a National 

Emergency concerning the Novel 

Coronavirus Disease (COVID–19), issued 

by the President on March 13, 2020. For 

assistance, contact FERC at 

FERCOnlineSupport@ferc.gov or call 

toll free, (866) 208–3676 or TTY, (202) 

502–8659. 

m. Individuals desiring to be included 

on the Commission’s mailing list should 

so indicate by writing to the Secretary 

of the Commission. 

n. Comments, Protests, or Motions to 

Intervene: Anyone may submit 

comments, a protest, or a motion to 

intervene in accordance with the 

requirements of Rules of Practice and 

Procedure, 18 CFR 385.210, .211, .214, 

respectively. In determining the 

appropriate action to take, the 

Commission will consider all protests or 

other comments filed, but only those 

who file a motion to intervene in 

accordance with the Commission’s 

Rules may become a party to the 

proceeding. Any comments, protests, or 

motions to intervene must be received 

on or before the specified comment date 

for the application. 

o. Filing and Service of Documents: 

Any filing must (1) bear in all capital 

letters the title ‘‘COMMENTS’’, 

‘‘PROTEST’’, or ‘‘MOTION TO 

INTERVENE’’ as applicable; (2) set forth 

in the heading the name of the applicant 

and the project number of the 

application to which the filing 

responds; (3) furnish the name, address, 

and telephone number of the person 

commenting, protesting or intervening; 

and (4) otherwise comply with the 

requirements of 18 CFR 385.2001 

through 385.2005. All comments, 

motions to intervene, or protests must 

set forth their evidentiary basis. Any 

filing made by an intervenor must be 

accompanied by proof of service on all 

persons listed in the service list 

prepared by the Commission in this 

proceeding, in accordance with 18 CFR 

385.2010. 

Dated: January 26, 2021. 

Kimberly D. Bose, 

Secretary. 

[FR Doc. 2021–02059 Filed 1–29–21; 8:45 am] 

BILLING CODE 6717–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

Federal Register / Vol. 86, No. 19 / Monday, February 1, 2021 / Notices 7725 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

CE21–004: Research Grants for 

Preventing Violence and Violence 

Related Injury. 

Date: May 25–26, 2021. 

Time: 8:30 a.m.–5:00 p.m., EDT. 

Place: Videoconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Mikel Walters, Ph.D., Scientific Review 

Officer, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone (404) 

639–0913, MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–02051 Filed 1–29–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

CE21–005, The CDC National Centers of 

Excellence in Youth Violence 

Prevention (YVPCs): Rigorous 

Evaluation of Prevention Strategies to 

Prevent and Reduce Community Rates 

of Youth Violence. 

Date: June 22–24, 2021. 

Time: 8:30 a.m.–5:00 p.m., EDT. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Mikel Walters, Ph.D., Scientific Review 

Officer, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone (404) 

639–0913, MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–02054 Filed 1–29–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 86 FR 6336–6340, dated 

January 20, 2021) is amended to reflect 

the Order of Succession for the Centers 

for Disease Control and Prevention. 

Section C–C, Order of Succession, is 

hereby amended as follows: 

Delete in its entirety Section C–C, 

Order of Succession, and insert the 

following: 

During the absence or disability of the 

Director, Centers for Disease Control 

and Prevention (CDC), or in the event of 

a vacancy in that office, the first official 

listed below who is available shall act 

as Director, except that during a 

planned period of absence, the Director 

may specify a different order of 

succession: 

1. Principal Deputy Director 

2. Chief Medical Officer 

3. Deputy Director for Public Health 

Service and Implementation 

Science 

4. Deputy Director for Infectious 

Diseases 

5. Deputy Director for Public Health 

Science and Surveillance 

6. Deputy Director for Non-Infectious 

Diseases 

7. Director, National Institute for 

Occupational Safety and Health 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2021–02093 Filed 1–29–21; 8:45 am] 

BILLING CODE 4160–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and